loading
Schlusskurs vom Vortag:
$59.33
Offen:
$57.99
24-Stunden-Volumen:
1.09M
Relative Volume:
0.52
Marktkapitalisierung:
$11.08B
Einnahmen:
$29.52M
Nettoeinkommen (Verlust:
$-567.06M
KGV:
-16.18
EPS:
-3.66
Netto-Cashflow:
$-551.11M
1W Leistung:
+1.86%
1M Leistung:
+26.85%
6M Leistung:
+45.51%
1J Leistung:
+6.05%
1-Tages-Spanne:
Value
$57.74
$59.68
1-Wochen-Bereich:
Value
$56.66
$60.08
52-Wochen-Spanne:
Value
$29.17
$62.40

Revolution Medicines Inc Stock (RVMD) Company Profile

Name
Firmenname
Revolution Medicines Inc
Name
Telefon
415-766-3638
Name
Adresse
700 SAGINAW DR, REDWOOD CITY, CA
Name
Mitarbeiter
700
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-06
Name
Neueste SEC-Einreichungen
Name
RVMD's Discussions on Twitter

Vergleichen Sie RVMD mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
RVMD
Revolution Medicines Inc
59.26 11.09B 29.52M -567.06M -551.11M -3.66
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
426.00 109.22B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
629.60 67.50B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
423.82 57.35B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
837.92 50.87B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
184.38 39.72B 447.02M -1.18B -868.57M -6.1812

Revolution Medicines Inc Stock (RVMD) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-10-21 Eingeleitet Mizuho Outperform
2025-10-16 Fortgesetzt Stifel Buy
2025-09-12 Fortgesetzt Raymond James Strong Buy
2025-09-05 Eingeleitet Truist Buy
2025-08-19 Eingeleitet Piper Sandler Overweight
2025-08-15 Eingeleitet Wells Fargo Overweight
2025-07-15 Eingeleitet Goldman Buy
2024-07-16 Bestätigt Needham Buy
2024-07-12 Eingeleitet Barclays Overweight
2024-07-08 Eingeleitet Jefferies Buy
2024-04-12 Bestätigt Needham Buy
2024-04-10 Hochstufung Raymond James Outperform → Strong Buy
2024-03-11 Eingeleitet Piper Sandler Overweight
2024-01-05 Hochstufung BofA Securities Neutral → Buy
2024-01-04 Eingeleitet Wedbush Outperform
2023-11-16 Eingeleitet Raymond James Outperform
2023-02-28 Hochstufung JP Morgan Neutral → Overweight
2022-12-14 Eingeleitet Needham Buy
2022-10-21 Eingeleitet Oppenheimer Outperform
2022-05-20 Eingeleitet BofA Securities Neutral
2022-03-01 Hochstufung Stifel Hold → Buy
2021-09-23 Eingeleitet Stifel Hold
2021-08-12 Herabstufung Goldman Buy → Neutral
2021-05-18 Eingeleitet Goldman Buy
2020-05-21 Eingeleitet H.C. Wainwright Buy
2020-03-09 Eingeleitet Cowen Outperform
2020-03-09 Eingeleitet Guggenheim Buy
2020-03-09 Eingeleitet JP Morgan Neutral
Alle ansehen

Revolution Medicines Inc Aktie (RVMD) Neueste Nachrichten

pulisher
09:27 AM

Revolution Medicines (NASDAQ:RVMD) Now Covered by Analysts at Royal Bank Of Canada - MarketBeat

09:27 AM
pulisher
07:26 AM

Revolution Medicines Inc (RVMD) Q3 2025: Everything You Need To Know Ahead Of Earnings - GuruFocus

07:26 AM
pulisher
06:47 AM

Should I hold or sell Revolution Medicines Inc. Equity Warrant stock in 2025Market Trend Review & Daily Stock Momentum Reports - newser.com

06:47 AM
pulisher
03:24 AM

What high frequency data says about Revolution Medicines Inc.Trade Risk Assessment & Accurate Technical Buy Alerts - newser.com

03:24 AM
pulisher
02:27 AM

How Revolution Medicines Inc. Equity Warrant stock performs in rising dollar environmentJuly 2025 Levels & Real-Time Stock Entry Alerts - newser.com

02:27 AM
pulisher
01:35 AM

Real time scanner hits for Revolution Medicines Inc. explainedMarket Risk Analysis & Consistent Return Strategy Ideas - newser.com

01:35 AM
pulisher
01:34 AM

Technical signs of recovery in Revolution Medicines Inc.July 2025 WrapUp & Daily Entry Point Trade Alerts - newser.com

01:34 AM
pulisher
Nov 03, 2025

Order flow analysis tools used on Revolution Medicines Inc.Portfolio Risk Report & AI Driven Price Predictions - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Will Revolution Medicines Inc. Equity Warrant stock remain a Wall Street favorite2025 Trade Ideas & Daily Oversold Stock Bounce Ideas - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Revolution Medicines (RVMD) Receives Outperform Rating from RBC Capital - GuruFocus

Nov 03, 2025
pulisher
Nov 03, 2025

Revolution Medicines a new outperform at RBC on RAS(ON) inhibitors for cancers - MSN

Nov 03, 2025
pulisher
Nov 03, 2025

Revolution Medicines is Best-Positioned to Execute Targeting RAS-Mutated Cancers, RBC Says - MarketScreener

Nov 03, 2025
pulisher
Nov 03, 2025

RBC Capital Initiates Coverage on RVMD with an 'Outperform' Rati - GuruFocus

Nov 03, 2025
pulisher
Nov 03, 2025

Why Revolution Medicines Inc. (42Z) stock is a strong analyst pickJuly 2025 Setups & Low Risk Profit Maximizing Plans - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

What MACD and RSI say about Revolution Medicines Inc. Equity Warrant2025 AllTime Highs & Low Risk Growth Stock Ideas - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Detecting price anomalies in Revolution Medicines Inc. with AITrade Analysis Summary & Target Return Focused Picks - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

What institutional flow reveals about Revolution Medicines Inc. Equity WarrantMarket Growth Summary & Verified Entry Point Signals - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Why Revolution Medicines Inc. Equity Warrant stock remains a top recommendation2025 Support & Resistance & Consistent Profit Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Applying sector rotation models to Revolution Medicines Inc. Equity WarrantJuly 2025 Review & Daily Chart Pattern Signals - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is Revolution Medicines Inc. Equity Warrant showing signs of accumulationMarket Trend Review & Free Reliable Trade Execution Plans - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

RBC Initiates Revolution Medicines at Outperform, Speculative Risk With $77 Price Target - MarketScreener

Nov 03, 2025
pulisher
Nov 03, 2025

Revolution Medicines, Summit Therapeutics Partner on RAS Inhibitor/Ivonescimab Combinations for Solid Tumors - MSN

Nov 03, 2025
pulisher
Nov 03, 2025

How analysts rate Revolution Medicines Inc. stock today2025 Top Decliners & Reliable Entry Point Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is Revolution Medicines Inc. a candidate for recovery playPortfolio Performance Report & Entry Point Confirmation Signals - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Revolution Medicines Inc. stock trend outlook and recovery pathJuly 2025 Volume & Real-Time Stock Price Movement Reports - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Technical signs of recovery in Revolution Medicines Inc. Equity WarrantTrade Analysis Report & Low Drawdown Investment Strategies - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Visual analytics tools that track Revolution Medicines Inc. Equity Warrant performancePortfolio Update Report & Stepwise Entry/Exit Trade Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is Revolution Medicines Inc. stock a bargain at current levels2025 Key Lessons & High Accuracy Investment Signals - newser.com

Nov 03, 2025
pulisher
Nov 02, 2025

How Revolution Medicines Inc. stock performs in rising dollar environmentTrade Ideas & Verified Stock Trade Ideas - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

How Revolution Medicines Inc. (42Z) stock reacts to weak economyMarket Risk Analysis & Reliable Price Action Trade Plans - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Published on: 2025-11-02 21:21:19 - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Using Bollinger Bands to evaluate Revolution Medicines Inc. Equity WarrantJuly 2025 Momentum & Risk Managed Investment Entry Signals - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

What makes Revolution Medicines Inc. (42Z) stock appealing to growth investors2025 Market Outlook & Daily Stock Trend Watchlist - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

What to expect from Revolution Medicines Inc. Equity Warrant in the next 30 days2025 Year in Review & Low Drawdown Momentum Ideas - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Is Revolution Medicines Inc. Equity Warrant stock a buy on dipsEarnings Growth Summary & Low Drawdown Investment Ideas - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Revolution Medicines shares climb after FDA grants Orphan Drug Designation for pancreatic cancer treatment - MSN

Nov 02, 2025
pulisher
Nov 02, 2025

Revolution Medicines Inc. Equity Warrant stock retracement – recovery analysisJuly 2025 Macro Moves & Smart Allocation Stock Reports - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Published on: 2025-11-02 01:57:56 - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

Revolution Medicines, Inc. (RVMD) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada

Nov 01, 2025

Finanzdaten der Revolution Medicines Inc-Aktie (RVMD)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$37.76
price up icon 1.24%
$28.93
price up icon 0.85%
$102.19
price up icon 0.70%
$104.59
price up icon 0.63%
biotechnology ONC
$311.51
price up icon 0.01%
$184.56
price down icon 0.84%
Kapitalisierung:     |  Volumen (24h):